About the Ghobrial Lab
Our mission: At the forefront of cutting-edge research, the Ghobrial Lab is spearheading Multiple Myeloma research. With unwavering commitment, we aspire to revolutionize the landscape of early detection and interception. Our team is devoted to identifying individuals at risk of B cell malignancies from precursor conditions such as Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) and developing targeted therapies to eliminate the disease before it progresses. We aim to identify the mechanisms of progression by analyzing the genetic, epigenetic, and immune alterations that govern the course multiple myeloma, ultimately striving towards a future where individuals live free from the burden of cancer. |